ENTERO

Entero Healthcare Solutions Ltd.

NSE: ENTERO

BSE: 544122

Sector: Consumer Services

Industry Group: Retailing

Industry: Pharmacy Retail

1,172.00-38.1 (-3.15%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

56.9 / 100

Value Score

57.0 / 100

Price Momentum Score

77.7 / 100

QVM Score

76.9 / 100

Key Metrics

Market Cap

5100.90

P/E (TTM)

44.34

P/B

3.02

P/S (TTM)

0.77

EV/EBITDA

20.57

CAPE (5Y)

118.54

ROE (TTM)

6.74

ROCE (TTM)

9.71

ROA (TTM)

3.65

Avg 3Y ROE

5.29

Earnings 3Y CAGR

Sales 3Y CAGR

25.93

Sales 5Y CAGR

29.93

Debt/Equity

0.40

Consensus TP

1488.50

Strong Buy %

Promoter Holding

52.42

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Entero Healthcare Solutions Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 77.7 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

77.7 / 100

Strong revenue growth and above median growth of market

The company delivered strong revenue growth of 29.35% for 12-month ended 31 Mar 2026 and the growth was 18.94 percentage points higher than median growth of market

What is Sales growth (1Y)?

Median: 10.41

Value 29.35

-7635.64179204992

Strong EPS growth and above median growth of market

The company delivered strong EPS growth of 21.32% for 12-month ended 31 Mar 2026 and the growth was 16.11 percentage points higher than median growth of market

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.4 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.18 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to market median P/E

PE TTM of 44.34 indicates that the stock is expensive on a standalone basis and is at a 92.95% premium to market median P/E

What is P/E Ratio?

Median: 22.98

Value 44.34

-4046.8170640.8

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -9.89% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low but stable ROE

The company reported low ROE of 6.74% for 12-month ended 31 Mar 2026 and ROE improved marginally by 110 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 3.38% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 62 bps from 1 year ago

What is Operating profit margin?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 42.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

42.7 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Entero Healthcare Solutions Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Entero Healthcare Solutions Ltd. Shareholding Pattern

Quarterly breakdown of Entero Healthcare Solutions Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	52.44	52.44	52.44	52.44	52.42	52.42	52.42	52.42	52.42
Indian Promoter	14.41	14.41	14.41	14.41	14.41	14.41	14.41	14.41	14.41
Foreign Promoter	38.03	38.03	38.03	38.03	38.01	38.01	38.01	38.01	38.01
Institutions	25.58	25.38	31.55	30.98	29.56	27.38	24.32	21.56	20.64
Mutual Funds / UTI	-	-	5.07	5.29	6.09	6.14	4.78	10.25	9.52
FI/Bank/Insurance	1.13	1.00	0.82	0.78	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-
FII	23.30	23.32	23.82	22.20	19.92	17.21	14.68	5.14	4.02
Other Institutions	1.15	1.06	1.84	2.71	3.54	4.05	4.86	6.17	7.10
Non-Institution	21.99	22.18	16.01	16.59	18.02	20.19	23.26	26.02	26.93
Bodies Corporate	0.68	0.77	0.92	1.05	1.12	1.42	2.08	1.91	1.95
Others (incl. Retail) No. of shareholders	21.31 80,784	21.41 66,293	15.09 36,639	15.54 32,943	16.90 32,877	18.77 33,035	21.18 35,987	24.11 39,952	24.98 38,719

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Microcap 250	0.23%	180 / 250
2	Nifty Total Market	0.01%	662 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Entero Healthcare Solutions Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Jayant Prakash KMP	August-2024	Market Sale (Disposal) 30th Aug 2024	0.01 %	₹ 1,321.97	2.18 k	₹ 28.81 lac
Jayant Prakash KMP	August-2024	Market Sale (Disposal) 22nd Aug 2024	0.01 %	₹ 1,315.00	1.35 k	₹ 17.75 lac
Abhitsh Kumar Designated Person	August-2024	Market Sale (Disposal) 20th Aug 2024	0.03 %	₹ 1,282.72	1.20 k	₹ 15.39 lac

No corporate action data available.

Company Profile

Overview of Entero Healthcare Solutions Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in In...

Key personnel

Ms. Sanu Vishal Kapoor

Compliance Officer, Vice President - General Counsel, Company Secretary

Mr. Prabhat AgrawalD

Chief Executive Officer, Managing Director (Promoter)

Mr. Prem SethiD

Whole-Time Director

Ms. Sumona ChakrabortyD

Nominee Director

Mr. Arun SadhanandhamD

Nominee Director

Mr. Rajesh Shashikant DalalD

Non-Executive Independent Director

Ms. Sandhya Gadkari SharmaD

Non-Executive Independent Director

Mr. Sujesh VasudevanD

Non-Executive Independent Director

View all

Incorporated on

10 Jan 2018

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

16 Feb 2024

Free Float

1,48,32,083

Website

https://www.enterohealthcare.com/

Phone no.

+912269019100

Address

UNIT NO 605 & 606, 6TH FLOOR,, TRADE CENTRE, BANDRA KURLA COMPLEX,, BANDRA EAST,, , 400051, India

Frequently Asked Questions

What is the current share price of Entero Healthcare Solutions Ltd.?

The current share price of Entero Healthcare Solutions Ltd. is ₹ 1,172.00 as of 8 Jul 2026.

What is the market capitalisation of Entero Healthcare Solutions Ltd.?

The market capitalisation of Entero Healthcare Solutions Ltd. stands at ₹ 5,100.90 Cr.

What is the PE ratio of Entero Healthcare Solutions Ltd.?

The Price-to-Earnings (PE) ratio of Entero Healthcare Solutions Ltd. is 44.34 as of the latest trailing twelve months data.

What is the ROE and ROCE of Entero Healthcare Solutions Ltd.?

Entero Healthcare Solutions Ltd. has a Return on Equity (ROE) of 6.74% and a Return on Capital Employed (ROCE) of 9.71% as per the latest financial reports.

What is the 52-week high and low of Entero Healthcare Solutions Ltd.?

The 52-week high of Entero Healthcare Solutions Ltd. is - and the 52-week low is -.

What is the dividend yield of Entero Healthcare Solutions Ltd.?

The dividend yield of Entero Healthcare Solutions Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Entero Healthcare Solutions Ltd.?

Foreign Institutional Investors (FII) hold 4.02%, Domestic Institutional Investors (DII) hold 9.52% and retail/public investors hold 24.98% of Entero Healthcare Solutions Ltd. shares.

What sector does Entero Healthcare Solutions Ltd. belong to?

Entero Healthcare Solutions Ltd. operates in the Consumer Services sector.

What is the beta of Entero Healthcare Solutions Ltd.?

The beta of Entero Healthcare Solutions Ltd. is 0.27, indicating its price volatility relative to the broader market. Over the past 1 year, Entero Healthcare Solutions Ltd. has delivered an absolute return of 2.38%.

What is the RSI of Entero Healthcare Solutions Ltd.?

The 14-day Relative Strength Index (RSI) of Entero Healthcare Solutions Ltd. is 50.21, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Entero Healthcare Solutions Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Entero Healthcare Solutions Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Holdings and Presence